CN100427473C - Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide - Google Patents

Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide Download PDF

Info

Publication number
CN100427473C
CN100427473C CNB2006101547228A CN200610154722A CN100427473C CN 100427473 C CN100427473 C CN 100427473C CN B2006101547228 A CNB2006101547228 A CN B2006101547228A CN 200610154722 A CN200610154722 A CN 200610154722A CN 100427473 C CN100427473 C CN 100427473C
Authority
CN
China
Prior art keywords
pyrazine
bromo
consumption
cuprous iodide
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006101547228A
Other languages
Chinese (zh)
Other versions
CN1962646A (en
Inventor
徐方羲
林旭锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CNB2006101547228A priority Critical patent/CN100427473C/en
Publication of CN1962646A publication Critical patent/CN1962646A/en
Application granted granted Critical
Publication of CN100427473C publication Critical patent/CN100427473C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesizing method of 2-cyano pyrazine as key intermediate of antitubercular drugs aldinamide, which comprises the following steps: adopting alkyl benzene as reacting solvent; making 1.5-3% cuprous iodide, potassium iodide and 1-1.5% N, N'-dimethyldiamine as composite catalyst; reacting 2, 2-difluobromobenzene and sodium cyanide with molar rate at 1: 1.0-2.0 protected by nitrogen at 100-150 Deg C for 20-48h; filtering; decompressing the filtrate; fractioning to obtain the product. The invention shortens reacting flow path, which is simple to feed and dispose.

Description

The synthetic method of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine
Technical field
The present invention relates to the medicine intermediate preparation method, relate in particular to a kind of synthetic method of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine.
Background technology
The important source material of 2 cyano pyrazine production for treating tuberculosis drug pyrazinamide.Therefore how efficiently Synthetic 2-cyanopyrazine receives people's huge concern.Synthetic more existing bibliographical informations of 2 cyano pyrazine have been reported the research of special catalyst catalysis 2-methylpyrazine prepared by ammoxidation 2 cyano pyrazine such as document " fine chemistry industry ".Document Applied Catalsis, 1986, cyclization dehydration dehydrogenation under catalyst action is 2 monomethyl pyrazines to the 20:219-222 report with quadrol and propylene glycol earlier, the High Temperature High Pressure catalytic ammoxidation is 2 one cyanopyrazines again.Document CN1398855 has reported that by adopting with 2-methylpyrazine, ammonia and oxygen be raw material, in temperature of reaction is 300~500 ℃, in the gauge pressure reaction pressure is under-0.05~0.05MPa condition, and raw material is by with vanadium, chromium catalyst system and non-imposed interpolation phosphorus and be selected from basic metal or the technical scheme of the fluid catalyst bed that alkaline-earth metal is formed is used for the industrial production of 2 cyano pyrazine.Document CN1408711 has reported the catalyzer that a kind of 2-methylpyrazine Synthetic 2-cyanopyrazine uses, and this catalyzer adopts metavanadic acid ammonia, Vanadium Pentoxide in FLAKES, and ammonium molybdate, phosphoric acid are through flooding the loaded catalyst of preparation system.Document CN1429820 has reported that a kind of oxidation proceses of ammonia prepares the method and the special-purpose catalyst of 2 cyano pyrazine, it is to be Primary Catalysts with vanadium, titanium, and phosphorus, iron, nickel, cobalt, bismuth, manganese, chromium, molybdenum, copper, zinc, tin, boron, potassium, lithium, magnesium etc. are the multicomponent catalyst of promotor.Above-mentioned these synthesis technique Preparation of Catalyst complexity, reaction process is long cycle time, the condition harshness, or have many experimentations to relate to variety of problems such as high-temperature and high-pressure conditions, low-yield, aftertreatment complexity.Thereby under the condition of gentleness, the synthesis technique that solves 2 cyano pyrazine efficiently is very important and urgent.
Summary of the invention
The synthetic method that the purpose of this invention is to provide a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine.
It is to be reaction solvent with the alkylbenzene; with cuprous iodide; potassiumiodide and N; N '-dimethyl-ethylenediamine is a combination catalyst; 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration; the filtrate decompression fractionation obtains 2 cyano pyrazine; the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; the consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; the consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.5 molar equivalent of 2-bromo-pyrazine, and reaction formula is:
Figure C20061015472200041
Described reaction solvent alkylbenzene is toluene, ethylbenzene or dimethylbenzene.
Reaction times is preferably 20~36 hours.Temperature of reaction is preferably 100~130 ℃.The molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is preferably 1: 1.0~and 1.5; The consumption of cuprous iodide is preferably 5~20% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is preferably 1.5~2.5 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are preferably 1~1.2 molar equivalent of 2-bromo-pyrazine.
The present invention compares with existing synthetic method, has the following advantages:
1) reaction conditions gentleness;
2) the reaction process flow process is short;
3) use cheap reagent;
4) feed intake and aftertreatment all very simple, be easy to realize industrialized production.
Embodiment
The molecular formula of 2 cyano pyrazine is:
Figure C20061015472200042
The concrete reactions steps of the synthetic method of anti-tuberculosis drugs pyrazinoic acid amide key intermediate 2 cyano pyrazine is as follows:
With the alkylbenzene is reaction solvent; with cuprous iodide, potassiumiodide and N, N '-dimethyl-ethylenediamine is a combination catalyst, and 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration, filtrate decompression fractionation obtain high yield, highly purified 2 cyano pyrazine.Wherein the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; The consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.5 molar equivalent of 2-bromo-pyrazine.Recommendation response solvent alkylbenzene is toluene, ethylbenzene, dimethylbenzene, and override is a toluene.The recommendation response time is 20~36 hours, and override is 24 hours.The recommendation response temperature is 100~130 ℃, and override is 110 ℃.Recommending the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~1.5, and override is 1: 1.2; The consumption of cuprous iodide is 5~20% molar equivalents of 2-bromo-pyrazine, and override is 10% molar equivalent; The consumption of potassiumiodide is 1.5~2.5 molar equivalents of cuprous iodide, and override is 2 molar equivalents; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.2 molar equivalent of 2-bromo-pyrazine, and override is 1 molar equivalent.
Following examples will help to understand the present invention, but be not limited to content of the present invention:
Embodiment 1
In 1 liter of three-necked bottle; add 500 milliliters of toluene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines, 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanides; 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent), 10 gram potassiumiodides (60 mmoles, 0.2 equivalent); 26.4 gram N; N '-dimethyl-ethylenediamine (0.3 mole, 1.0 equivalents), under nitrogen protection 110 ℃ of stirring reactions 30 hours; finish reaction; subsequent filtration, the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 70%; purity 99% (GC), 84~87 ℃ of boiling points (18-20mmHg).
Embodiment 2
In 1 liter of three-necked bottle; add 500 milliliters of ethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent); 10 gram potassiumiodides (60 mmoles, 0.2 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 120 ℃ of stirring reactions 25 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 73%, purity 99%.
Embodiment 3
In 1 liter of three-necked bottle; add 500 milliliters of toluene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 5.73 gram (30 mmoles; 0.1 cuprous iodide equivalent); 11 gram potassiumiodides (66 mmoles, 0.22 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 105 ℃ of stirring reactions 36 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 71%, purity 99%.
Embodiment 4
In 1 liter of three-necked bottle; add 500 milliliters of ethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 19.8 gram (0.6 mole, 2 equivalents) sodium cyanide, 2.83 gram (15 mmoles; 0.05 cuprous iodide equivalent); 10 gram potassiumiodides (60 mmoles, 0.3 equivalent), 39 gram N; (0.45 mole of N '-dimethyl-ethylenediamine; 1.5 equivalent), under nitrogen protection,, finish reaction 130 ℃ of stirring reactions 205 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 77%, purity 99%.
Embodiment 5
In 1 liter of three-necked bottle; add 500 milliliters of dimethylbenzene under the nitrogen protection successively; 48 gram (0.3 mole) 2-bromo-pyrazines; 11.8 gram (0.36 mole, 1.2 equivalents) sodium cyanide, 17.2 gram (90 mmoles; 0.3 cuprous iodide equivalent); 22 gram potassiumiodides (132 mmoles, 0.44 equivalent), 26.4 gram N; (0.3 mole of N '-dimethyl-ethylenediamine; 1.0 equivalent), under nitrogen protection,, finish reaction 100 ℃ of stirring reactions 48 hours; subsequent filtration; the filtrate decompression fractionation obtains the transparent liquid 2 cyano pyrazine, productive rate 72%, purity 99%.

Claims (5)

1. the synthetic method of an anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine; it is characterized in that it is is reaction solvent with the alkylbenzene; with cuprous iodide; potassiumiodide and N; N '-dimethyl amine is a combination catalyst; 2-bromo-pyrazine and sodium cyanide reacted 20~48 hours at 100~150 ℃ under nitrogen protection; subsequent filtration; the filtrate decompression fractionation obtains 2 cyano pyrazine; the molar equivalent ratio of 2-bromo-pyrazine and sodium cyanide is 1: 1.0~2.0; the consumption of cuprous iodide is 5~30% molar equivalents of 2-bromo-pyrazine; the consumption of potassiumiodide is 1.5~3 molar equivalents of cuprous iodide; N; the consumption of N '-dimethyl-ethylenediamine is 1~1.5 molar equivalent of 2-bromo-pyrazine, and reaction formula is:
Figure C2006101547220002C1
2. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that described reaction solvent alkylbenzene is toluene, ethylbenzene or dimethylbenzene.
3. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that the described reaction times is 20~36 hours.
4. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1 is characterized in that described temperature of reaction is 100~130 ℃.
5. the synthetic method of a kind of anti-tuberculosis drugs pyrazinoic acid amide intermediate 2 cyano pyrazine according to claim 1, the molar equivalent ratio that it is characterized in that described 2-bromo-pyrazine and sodium cyanide is 1: 1.0~1.5; The consumption of cuprous iodide is 5~20% molar equivalents of 2-bromo-pyrazine; The consumption of potassiumiodide is 1.5~2.5 molar equivalents of cuprous iodide; N, the consumption of N '-dimethyl-ethylenediamine are 1~1.2 molar equivalent of 2-bromo-pyrazine.
CNB2006101547228A 2006-11-21 2006-11-21 Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide Expired - Fee Related CN100427473C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101547228A CN100427473C (en) 2006-11-21 2006-11-21 Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101547228A CN100427473C (en) 2006-11-21 2006-11-21 Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide

Publications (2)

Publication Number Publication Date
CN1962646A CN1962646A (en) 2007-05-16
CN100427473C true CN100427473C (en) 2008-10-22

Family

ID=38081892

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101547228A Expired - Fee Related CN100427473C (en) 2006-11-21 2006-11-21 Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide

Country Status (1)

Country Link
CN (1) CN100427473C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113227036B (en) * 2018-12-26 2023-04-11 中国人民解放军军事科学院军事医学研究院 Ethylenediamine compound and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419272A (en) * 1981-02-28 1983-12-06 Degussa Ag Catalysts for the production of 2-cyanopyrazine
EP0253360A2 (en) * 1986-07-15 1988-01-20 Koei Chemical Co., Ltd. Process for preparing nitriles
CN1398855A (en) * 2001-07-20 2003-02-26 中国石油化工股份有限公司 Ammoxidation process of preparing 2-cyano pyrazine
CN1398856A (en) * 2001-07-20 2003-02-26 中国石油化工股份有限公司 Fluidized bed catalyst for preparing 2-cyano pyrazine
CN1408711A (en) * 2002-09-24 2003-04-09 天津大学 Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method
CN1429820A (en) * 2003-01-15 2003-07-16 邯郸市赵都精细化工厂 Method of preparing 2-cyanopyrazine by ammonia oxidation method and its special catalyst
JP2005289962A (en) * 2004-04-05 2005-10-20 Ms Jubilant Organosys Ltd Method for preparing cyanopyrazine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419272A (en) * 1981-02-28 1983-12-06 Degussa Ag Catalysts for the production of 2-cyanopyrazine
EP0253360A2 (en) * 1986-07-15 1988-01-20 Koei Chemical Co., Ltd. Process for preparing nitriles
CN1398855A (en) * 2001-07-20 2003-02-26 中国石油化工股份有限公司 Ammoxidation process of preparing 2-cyano pyrazine
CN1398856A (en) * 2001-07-20 2003-02-26 中国石油化工股份有限公司 Fluidized bed catalyst for preparing 2-cyano pyrazine
CN1408711A (en) * 2002-09-24 2003-04-09 天津大学 Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method
CN1429820A (en) * 2003-01-15 2003-07-16 邯郸市赵都精细化工厂 Method of preparing 2-cyanopyrazine by ammonia oxidation method and its special catalyst
JP2005289962A (en) * 2004-04-05 2005-10-20 Ms Jubilant Organosys Ltd Method for preparing cyanopyrazine

Also Published As

Publication number Publication date
CN1962646A (en) 2007-05-16

Similar Documents

Publication Publication Date Title
CN102898264B (en) Catalytic preparation process for aromatic nitrile or heteroaromatic nitrile
CN104628548A (en) Method for preparing acetophenone by bionic catalytic oxidation of ethylbenzene
SA515360954B1 (en) Process for preparing EDA using SO2-free hydrocyanic acid
CN101912779B (en) Catalyst for catalytic synthesis of N-methylpyrrolidine and application thereof
CN104557564B (en) Preparation method of phenylmethylamine
CN100427473C (en) Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide
Saha et al. Recent advancements of replacing existing aniline production process with environmentally friendly one-pot process: An overview
CN101445459A (en) Method for synthesizing 2, 4-dichloroaniline
CN111732612B (en) Iron complex containing diphospho-m-carborane ligand and preparation method and application thereof
García-Lacuna et al. A catalytic scalable Pauson–Khand reaction in a plug flow reactor
CN101147867B (en) Fluidized bed catalyst for oxidation of propene ammonia
CN100484925C (en) Preparation process of intermediate 2-cyanpyrazine of pyrazinamide drug
CN104276976A (en) Method for preparing imine structure compound by amine catalytic oxidation
CN108191814B (en) Method for synthesizing cyclohexanone ethylene ketal under catalysis of titanium ammonium phosphotungstate composite salt
CN1189462C (en) Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method
CN109748817B (en) Method for synthesizing aliphatic nitrile from aliphatic aldehyde
CN110668972B (en) Preparation method of 3, 4-dimethoxy benzonitrile
CN102746185A (en) Preparation process of aromatic nitrile compound
CN100457721C (en) Process for preparing 2,4-difluorocyanobenzene
CN104525240A (en) Application method of ferric nitrate as catalyst in reaction of benzene and hydroxylammonium salt for preparing aniline by one-step-method
CN112939811B (en) Preparation method of aromatic nitrile compound
TW467898B (en) Process for coproducing a cyclic lactam and a cyclic amine
CN113649060B (en) Catalyst for synthesizing 1, 3-propylene diamine, preparation method and application thereof
CN100427462C (en) Process for preparing 2,4-difluoro benzonitril
CN100408173C (en) Acrylonitrile catalyst of containing calcium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081022

Termination date: 20111121